Acrolein, an I-κBα-independent downregulator of NF-κB activity, causes the decrease in nitric oxide production in human malignant keratinocytes

Archives of Toxicology

Volumn 85, Issue 5, 2011, Pages 499-504

  Moon, Ki Young ^a  

^a Gwangju Health College University   (South Korea)

Author keywords

Acrolein; Chemical carcinogenesis; Human malignant keratinocytes; I B; NF B activity; Nitric oxide

Indexed keywords

ACROLEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SERINE;

ARTICLE; CELL ACTIVITY; CHEMICAL CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACROLEIN; ALKYLATING AGENTS; CARCINOGENS; CELL LINE, TUMOR; DOWN-REGULATION; EPIDERMIS; HUMANS; I-KAPPA B PROTEINS; KERATINOCYTES; LIPOPOLYSACCHARIDES; NF-KAPPA B; NITRIC OXIDE; PHOSPHORYLATION;

EID: 79956341287     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-010-0599-4     Document Type: Article

References (32)

1. PA Baeuerle D Baltimore 1988 I kappa B: a specific inhibitor of the NF-kappa B transcription factor Science 242 540 546 3140380 10.1126/science. 3140380 1:CAS:528:DyaL1cXmt1yiuro%3D (Pubitemid 18263193)
2. PA Bécherel L Le Goff S Ktorza F Ouaaz JM Mencia-Huerta B Dugas P Debré MD Mossalayi M Arock 1995 Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes Eur J Immunol 25 2992 2995 7589103 10.1002/eji.1830251042
3. PA Bécherel O Chosidow L Le Goff C Francès P Debré MD Mossalayi M Arock 1997 Inducible nitric oxide synthase and proinflammatory cytokine expression by human keratinocytes during acute urticaria Mol Med 3 686 694 9392005 (Pubitemid 28008374)
4. S Biswal G Acquaah-Mensah K Datta X Wu JP Kehrer 2002 Inhibition of cell proliferation and AP-1 activity by acrlein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications Chem Res Toxicol 15 180 186 11849044 10.1021/tx015552p 1:CAS:528:DC%2BD38Xlt1Sqsg%3D%3D (Pubitemid 34163798)
5. K Bomsztyk JW Rooney T Iwasaki NA Rachie SK Dower CH Sibley 1991 Evidence that interleukin-1 and phorbol esters activate NF-κB by different pathways: role of protein kinase C Cell Regul 2 329 335 2059661 1:CAS:528:DyaK3MXkt1Ons7o%3D
6. V Bours E Dejardin F Goujon-Letawe MP Merville V Castronovo 1994 The NF-kappa B transcription factor and cancer: high expression of NF-kappa B-and I kappa B-relared proteins in tumor cell lines Biochem Pharmacol 47 145 149 8311838 10.1016/0006-2952(94)90448-0 1:CAS:528:DyaK2cXhs1Sgsbo%3D (Pubitemid 24045827)
7. V Bours M Bentires-Alj A-C Hellin P Viatour P Robe S Delhalle V Benoit M-P Merville 2000 Nuclear factor-κB, cancer, and apoptosis Biochem Pharmacol 60 1085 1090 11007945 10.1016/S0006-2952(00)00391-9 1:CAS:528:DC%2BD3cXmslOjsb8%3D
8. DE Heck DL Laskin CR Gardner JD Laskin 1992 Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing J Biol Chem 267 21277 21280 1383221 1:CAS:528:DyaK38Xls1Ckt78%3D
9. ND Horton SS Biswal LL Corrigan J Bratta JP Kehrer 1999 Acrolein causes inhibitor κB-independent decreases in nuclear factor κB activation in human lung adenocarcinoma (A549) cells J Biol Chem 274 9200 9206 10092592 10.1074/jbc.274.14.9200 1:CAS:528:DyaK1MXisVWlsbw%3D (Pubitemid 29180225)
10. T Huxford DB Huang S Malek G Ghosh 1998 The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappa B inactivation Cell 95 759 770 9865694 10.1016/S0092-8674(00)81699-2 1:CAS:528:DyaK1MXivVGr (Pubitemid 29014456)
11. M Karin Y Ben-Neriah 2000 Phosphorylation meets ubiquitination: the control of NF-κB activity Annu Rev Immunol 18 621 663 10837071 10.1146/annurev.immunol.18.1.621 1:CAS:528:DC%2BD3cXjs1Gmtro%3D (Pubitemid 30365393)
12. C Lambert J Li K Jonscher TC Yang P Reigan M Quintana J Harvey BM Freed 2007 Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain J Biol Chem 282 19666 19675 17491020 10.1074/jbc.M611527200 1:CAS:528:DC%2BD2sXntFWrtrg%3D (Pubitemid 47100056)
13. SH Lee SY Lee DJ Son H Lee HS Yoo S Song KW Oh DC Han BM Kwon JT Hong 2005 Inhibitory effect of 2'-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-κB activation in RAW 264.7 cells Biochem Pharmacol 69 791 799 15710356 10.1016/j.bcp.2004.11.013 1:CAS:528: DC%2BD2MXhtlCrsb8%3D (Pubitemid 40248621)
14. S Legrand-Poels L Zecchinon B Piret S Schoonbroodt J Piette 1997 Involvement of different transduction pathways in NF-κB activation by several inducers Free Rad Res 27 301 309 10.3109/10715769709065768 1:CAS:528:DyaK2sXmvFyku78%3D (Pubitemid 27474889)
15. L Li RF Hamilton Jr A Holian 1999 Effect of acrolein on human alveolar macrophage NF-kappaB activity Am J Physiol 277 3 Pt 1 L550 L557 10484462 1:CAS:528:DyaK1MXmt1altbg%3D
16. S Moncada RMJ Palmer EA Higgs 1991 Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 109 140 1852778 1:CAS:528:DyaK3MXmt1amtLw%3D
17. K-Y Moon 2007 The chemopreventive effect of retinoids on cellular NF-κB activity induced by NMU and NEU in human malignant keratinocytes Cancer Res Treat 39 82 87 19746216 10.4143/crt.2007.39.2.82
18. K-Y Moon 2010 N-nitroso-N-methylurea and N-nitroso-N-ethylurea induce upregulation of cellular NF-κB activity through protein kinase C-dependent pathway in human malignant keratinocytes Arch Pharm Res 33 133 139 20191354 10.1007/s12272-010-2235-5 1:CAS:528:DC%2BC3cXitV2itLc%3D
19. K-Y Moon B-S Hahn J Lee YS Kim 2001 A cell-based assay system for monitoring NF-κB activity in human HaCaT transfectant cells Anal Biochem 292 17 21 11319812 10.1006/abio.2001.5059 1:CAS:528:DC%2BD3MXivFalu7c%3D (Pubitemid 32417717)
20. K-Y Moon YJ Lee YS Kim 2003 Upregulation of cellular NF-κB activity by alkylating carcinogens in human epidermal keratinocytes Biol Pharm Bull 26 1195 1197 12913277 10.1248/bpb.26.1195 1:CAS:528:DC%2BD3sXns1Slt7c%3D (Pubitemid 40012591)
21. RG Nath JE Ocando FL Chung 1996 Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodents and human tissues Cancer Res 56 452 456 8564951 1:CAS:528:DyaK28XnslKqtg%3D%3D (Pubitemid 26048600)
22. C Nathan Q-W Xie 1994 Nitric oxide synthases: roles, tolls, and controls Cell 78 915 918 7522969 10.1016/0092-8674(94)90266-6 1:CAS:528: DyaK2cXmsV2jsLg%3D (Pubitemid 24292319)
23. P Perez A Page JL Jorcano 2000 Role of phosphorylated p50-NF-κB in the ultraviolet response of mouse skin Mol Carcinog 27 272 279 10747291 10.1002/(SICI)1098-2744(200004)27:4<272::AID-MC5>3.0.CO;2-P 1:CAS:528:DC%2BD3cXisVWis7s%3D (Pubitemid 30191997)
24. B Rayet C Gelinas 1999 Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 6938 6947 10602468 10.1038/sj.onc.1203221 1:CAS:528:DyaK1MXotVyhtb4%3D
25. C Roméro-Graillet E Aberdam M Clément J-P Ortonne R Ballotti 1997 Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis J Clin Invest 99 635 642 9045865 10.1172/JCI119206 (Pubitemid 27097664)
26. C Saliou M Kitazawa L McLaughlin J-P Yang JK Lodge T Tetsuka K Iwasaki J Cillard T Okamoto L Packer 1999 Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line Free Radic Biol Med 26 174 183 9890652 10.1016/S0891-5849(98)00212-3 1:CAS:528:DyaK1MXhsFyq
27. DA Scudiero RH Shoemaker KD Paull A Monks S Tierney TH Nofziger MJ Currens D Seniff MR Boyd 1988 Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines Cancer Res 48 4827 4833 3409223 1:CAS:528:DyaL1cXls1arsrk%3D
28. SJ Seo HG Choi HJ Chung CK Hong 2002 Time course of expression of mRNA of inducible nitric oxide synthase and generation of nitric oxide by ultraviolet B in keratinocyte cell lines Br J Dermatol 147 655 662 12366409 10.1046/j.1365-2133.2002.04849.x 1:CAS:528:DC%2BD38Xosl2qt7k%3D (Pubitemid 35286148)
29. MB Toledano WJ Leonard 1991 Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro Proc Natl Acad Sci USA 88 4328 4332 1903539 10.1073/pnas.88.10.4328 1:CAS:528:DyaK3MXksVCms7g%3D (Pubitemid 21914533)
30. EB Traenckner HL Pahl T Henkel KN Schmidt S Wilk PA Baeuerle 1995 Phosphorylation of human I-kappaB-alpha on serines 32 and 36 controls I kappaB-alpha proteolysis and NF-kappa B activation in response to diverse stimuli EMBO J 14 2876 2883 7796813 1:CAS:528:DyaK2MXms1CktLs%3D
31. G Valacchi E Pagnin A Phung M Nardini BC Schock CE Cross A Van Der Vliet 2005 Inhibition of NF-kappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein Antioxid Redox Signal 7 25 31 15650393 10.1089/ars.2005.7.25 1:CAS:528:DC%2BD2MXhsFSmug%3D%3D (Pubitemid 40187922)
32. HH Versteeg E Nijhuis GR van den Brink M Evertzen GN Pynaert SJ van Deventer PJ Coffer MP Peppelenbosch 2000 A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein Biochem J 350 717 722 10970784 10.1042/0264-6021:3500717 1:CAS:528:DC%2BD3cXntlCmur4%3D